Human Papilloma Virus (HPV) vaccination

The HPV vaccine currently in use covers the two most important
types (strains 16 and 18) which cause 70 to 75 per cent of
cervical cancer.
The HPV vaccination programme started in September 2008
with all 12 to 13 year old and 17 to 18 year old girls being offered
the vaccine.
It will be many years before the vaccination programme has an effect upon cervical cancer incidence so the screening programme is not yet planning any changes.

Vaccinated women are advised to continue accepting their invitations for cervical screening as the vaccination will not prevent all types of cervical cancer.

Comments are closed.